VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1037738
Sex: F
Age:
State:

Vax Date: 01/19/2021
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she almost had all the side effects: she has no energy, been laying around for 6 days and felt like she have the flu or a cold, Thursday night (unspecified date), she had injection site pain, felt tired, has headache, muscle pain, chills, joint pain and fever. She has gotten better but now she has headache and can't get out of bed, feel dizzy. The patient recovered from the chills and fever on an unspecified date. Outcome of other events was not recovered and she was wondering when will all the other symptoms will go away, The patient was scheduled for 2nd dose on 14Feb2021. Follow-up attempts are completed. The following information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 1037739
Sex: F
Age:
State: NM

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: This is a spontaneous report from a contactable pharmacist. A non-pregnant (not pregnant at the time of vaccination) 61-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot number: EN5318), intramuscular, first dose on 23Jan2021 09:45 at single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was seated in observation area for a 30 minute observation after injection of COVID-19 vaccine on 23Jan2021 09:45. At 10:00, after 5-10 minutes stated she had tingling to tongue and lips. Shaking noted to hands and patient stated she felt numbness to upper extremities with dizziness then felt light headed. Patient transported to first aid room for further assessment and observation. Patient was alert and oriented (A&O) x4, lungs clear to auscultation. Patient also stated she felt like she needed to take a "deep breath". Patient had O2Sat of 95% on room air (RA) and blood pressure (B/p) of 130/80. At 10:16, physician ordered to give patient 12.5mg of diphenhydramine (BENADRYL) liquid oral 1 dose with 16oz of water intake during observation period. Patient was continuously monitored and noted that was able to ambulate at 10:25 to bathroom with assistance but still experiencing dizziness. Patient was monitored for a total of 45 minutes then discharged home. Facility where the most recent COVID-19 vaccine was administered was at a public health clinic/veterans administration facility. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered on 23Jan2021 10:30. Case was reported as non-serious.

Other Meds:

Current Illness:

ID: 1037740
Sex: F
Age:
State: MN

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK9231), via an unspecified route of administration in the left arm on 25Jan2021 (at the age of 22-years-old) as a single dose for COVID-19 immunization. Medical history included sulfa allergy, depression, and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN), citalopram (MANUFACTURER UNKNOWN), and ibuprofen (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162B2 on 08Jan2021 (at the age of 21-years-old; Lot Number: EK9231) for COVID-19 immunization in the left arm. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines (except the first dose) within four weeks prior to the vaccination. On 25Jan2021, hours after the second dose, the patient had severe full body flu like aches, lingering joint pain/some joint, dizziness, exhaustion, and weakness. On 26Jan2021, the patient had soreness at injection sight red and swollen. The patient did not receive any treatment for the events. The clinical outcomes of the full body flu like aches, lingering joint pain/some joint, dizziness, exhaustion, weakness, and soreness injection sight red and swollen were recovering.

Other Meds: DULOXETINE; CITALOPRAM; IBUPROFEN

Current Illness:

ID: 1037741
Sex: F
Age:
State: VA

Vax Date: 01/24/2021
Onset Date: 01/25/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: This is a spontaneous report from a contactable pharmacist. A 63-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in the left arm, on 24Jan2021 14:00 at SINGLE DOSE for covid-19 immunization. Medical history included hypertension, covid-19 (prior to vaccination, patient was diagnosed with COVID-19), latex allergy. Patient was not pregnant at the time of vaccination. Patient received covid-19 vaccine (lot number: EJ1686) Intramuscular in Left arm, on 02Jan2021 at 5:00pm, for covid-19 immunization and experienced only arm pain, chills, and tiredness, and headache. The first dose was much better tolerated. Concomitant medication included hydrochlorothiazide (HYDROCHLORTHIAZID), potassium chloride and calcium, colecalciferol (CITRACAL). On 25Jan2021 17:00, the patient experienced swelling at the injection site, injection site felt hot, arm pain, tiredness, chills, headache, nausea started at 27 hours (feeling bloated and nauseous), feeling unwell in general 27 hours after injection. The patient underwent lab tests and procedures on 26Jan2021, which included COVID-19 Nasopharynx: results pending. The outcome of events was recovered. Patient did not receive any treatment for events. Since the vaccination, the patient hasn't been tested for COVID-19. No follow-up attempts are possible. No further information is expected. Information on the batch/lot number has been obtained.

Other Meds: HYDROCHLORTHIAZID; POTASSIUM CHLORIDE; CITRACAL [CALCIUM;COLECALCIFEROL]

Current Illness:

ID: 1037742
Sex: F
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: arm soreness; chills; body aches; feverish; nauseous; throwing up; feel very hot; This is a spontaneous report from a non-contactable consumer (patient). A 26-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration in Jan2021 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant at the time of vaccination. It was reported that upon administration of the vaccine there was arm soreness that persisted throughout the day. Around 12-14 hours after receiving the vaccine, the patient started having chills, body aches, and felt feverish. The patient also started to feel nauseous as well and ended up throwing up several times. It was reported that the adverse events started on 26Jan2021 (21:00) (as reported). The morning after (date unspecified) the symptoms resolved; however, the patient now feel very hot and the arm soreness was still present. The outcome of events arm soreness and feeling hot was not recovered, while the outcome of other events was recovered in Jan2021. The patient has not been tested for COVID-19 since the vaccination. There was no treatment received for the adverse events. The events were reported as non-serious. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1037743
Sex: F
Age:
State: SC

Vax Date: 01/06/2021
Onset Date: 01/13/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: This is a spontaneous report from a contactable nurse (patient). A 25-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EJ1685, via an unspecified route of administration in the right arm on 06Jan2021 12:00 at SINGLE DOSE for covid-19 immunization. Medical history included systemic lupus, panic disorder, GERD (gastrooesophageal reflux disease) and covid-19 (Prior to vaccination, the patient was diagnosed with COVID-19). Concomitant medications included ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE), omeprazole, fluoxetine, cetirizine hydrochloride (ZYRTEC). The patient previously took lorabid and experienced allergies. On 13Jan2021 17:00, the patient experienced fatigue, fever (101+), muscle aches, joint aches, nausea and headaches. The patient underwent lab tests and procedures on 14Jan2021 which included nasal swab: negative. The outcome of events was recovered. Patient did not receive any treatment for the events. No follow-up attempts are possible. No further information is expected. Information on the batch/lot number has been obtained.

Other Meds: JUNEL FE; OMEPRAZOLE; FLUOXETINE; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1037744
Sex: F
Age:
State: CT

Vax Date: 01/20/2021
Onset Date: 01/23/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: This is a spontaneous report from a contactable other hcp (patient). A 48-year-old female patient at same age receive first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Jan2021 13:15 on right arm at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced extreme fatigue for a few days on 23Jan2021. The outcome of event was recovered. She is not pregnant. There was no treatment AE, no covid prior vaccination and no covid tested post vaccination. Information about Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 1037745
Sex: F
Age:
State:

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: This is a spontaneous report from a non-contactable healthcare professional. An 87-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN5318), intramuscular in right arm, on 25Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. During her 15-minute waiting period after the injection on 25Jan2021, the patient began to experience burning in her throat. The patient denied difficulty breathing, difficulty swallowing, and throat tightness. They were monitoring the patient for severe reaction symptoms, including but not limited to treatment including antihistamines. Follow-up response to treatment was good. The patient was discharged - stable to go home and was asked to follow-up with primary care physician for rapid progression of symptoms and respiratory distress (if observed). The patient recovered from the event on 25Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1037746
Sex: F
Age:
State: SC

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: This is a spontaneous report from a contactable consumer (patient). This 39-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown), intramuscular in left deltoid in Jan2021 (reported as 06Jan2021 or 07Jan2021 at 11:30) at a single dose for COVID-19 immunization. There were no medical history and concomitant medications. The patient received the first dose of bnt162b2 on 16Dec2020 at around 19:30, intramuscular injection in left deltoid. A day after vaccination, since an unspecified date in Jan2021, the patient's lymph nodes were swollen for 3 weeks at the time of report. The swelling went down some but was still very noticeable. Outcome of the event was recovering. Event did not require a visit to emergency room or physician office. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037747
Sex: F
Age:
State: MA

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: This is a spontaneous report from a contactable other health care professional (patient self-reported). A 29-year-old female patient (who was not pregnant at the time of vaccination), received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number; EL3247 and expiry date was not provided), via an unspecified route of administration, at arm Right on 26Jan2021, at a single dose for COVID-19 immunization, in Workplace clinic. Patient's medical history was reported as none and concomitant medications were not reported. Patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not received any other vaccines within 2 weeks of vaccination of COVID vaccine. On same day (26Jan2021), the patient experienced soreness in right arm and it is persistent after 24hours. Patient was not received any treatment for the event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Seriousness of the event was reported as non serious. Outcome of the event was recovering.

Other Meds:

Current Illness:

ID: 1037748
Sex: F
Age:
State: NH

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Headache; This is a spontaneous report from a contactable consumer (patient herself). A non-pregnant (not pregnant at the time of vaccination) 49-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot number: EL3247), at age 49 years, via an unspecified route of administration on the left arm, first dose on 26Jan2021 13:15 at single dose, for COVID-19 immunization. Medical history included allergy to Neoprene and had contact dermatitis due to it on an unspecified date. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received no other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient experienced headache 26Jan2021 20:00. Facility where the most recent COVID-19 vaccine was administered was at a workplace clinic. Since the vaccination, the patient has not been tested for COVID-19. Therapeutic measures were taken as a result of headache which includes ibuprofen (ADVIL). The outcome of the event was recovered on an unspecified date. Case was reported as non-serious.

Other Meds:

Current Illness:

ID: 1037749
Sex: U
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: generalized malaise; arm pain; headache; earache; This is a spontaneous report from contactable consumer reported for his cousin via Representative. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced arm pain, headache, earache and generalized malaise. The outcome was unknown. Information on the Lot/Batch number has been requested

Other Meds:

Current Illness:

ID: 1037750
Sex: F
Age:
State: NJ

Vax Date: 01/21/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on right arm on 21Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced sore arm on Jan2021. It still fets sore only if she presses on it. The outcome of event was unknown. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1037751
Sex: F
Age:
State: CA

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: A 74-years-old female patient received BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine, via an unspecified route of administration on 27Jan2021, at 74 yeras of age, at single dose for COVID-19 immunization. The patient's medical history included allergy to codine. The patient was not pregnant at the time of vaccination. The patient has not been tested for COVID-19 since the vaccination. Concomitant medication included fluoxetine hydrochloride (PROZAC). On 27Jan2021 by 15:00 the patient felt extremely tired and her eyes burned a lot. The reported events resolved on an unknown date without any treatment. . Information on the lot/batch number has been requested.

Other Meds: PROZAC

Current Illness:

ID: 1037752
Sex: M
Age:
State: MO

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 61-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL1284) on 26Jan2021 13:15 at single dose in left arm for COVID-19 immunisation. Age at vaccination was 61 years. The vaccine was administered at Doctor's office/urgent care. No other vaccine was given within 4 weeks prior to the COVID vaccine. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL1284) received on 05Jan2021 at 01:30 PM at single dose in left arm and the patient experienced sore arm. Medical history included Supraventricular tachycardia (SVT), Herpes, Hyperlipidemia, idiopathic mesenteric lymphadenopathy. The patient has no known allergies to medications, food, or other products. Concomitant medications included Valacyclovir, cyclobenzaprine, Metoprolol, lipitor. The patient reported second dose 8 hours post headache, sore arm and entire upper torso pain, chills and fever 101-102F 12 hrs. Patient was lethargic the whole next day with severe headache. Normal 2nd day after. Adverse events start date was reported as 26Jan2021 16:00. No treatment was received for the events. The events were reported as non serious. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19. The events were resolving (as reported).

Other Meds: VALACYCLOVIR [VALACICLOVIR]; CYCLOBENZAPRINE; METOPROLOL; LIPITOR [ATORVASTATIN]

Current Illness:

ID: 1037753
Sex: F
Age:
State:

Vax Date: 01/25/2021
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 25Jan2021 at single dose for COVID-19 immunisation. The patient medical history and the concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 5Jan2021 at single dose for COVID-19 immunisation. The patient received the Dose 1 of the Pfizer-BioNTech COVID-19 Vaccine last 05Jan2021, and Dose 2 on 25Jan2021. She mentioned that she was not sure if the second dose was administered properly. She "isn't sure" she received her second dose correctly. She was worried because, she stated, "I have lower efficacy because I'm on Budesonide." She was calling to ask if it is possible to get a third dose and if so, how long would it be before she could get it. She states she had a sore arm after the second dose. The event was assessed non-serious. Information about lot/batch has been requested.

Other Meds:

Current Illness:

ID: 1037754
Sex: F
Age:
State:

Vax Date: 12/01/2020
Onset Date: 12/01/2020
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: This is a spontaneous report from a non-contactable nurse (patient herself). This 53-year-old female nurse received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route, in Dec2020 at a single dose for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. After the first shot she had moderate pain at injection site for a few days, and fatigue for at least one day. The events were assessed as non-serious. Both events resolved on unknown date. No follow-up attempts are possible. No further information is expected. Information about lot/batch cannot be obtained.

Other Meds:

Current Illness:

ID: 1037755
Sex: F
Age:
State: FL

Vax Date: 01/05/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) Batch/lot number: EK9231, intramuscularly into the left arm on 05Jan2021 at single dose for covid-19 vaccination. Medical history included in Dec2020 around 23Dec2020 she tested positive for Covid-19. There were no concomitant medications. Patient said that because of the time of her retirement, she went to the VA and got the vaccination the first week of Jan2021. She said that with the first vaccination she said that she had chills, fever, and her arm hurt real bad. She said that her symptoms came on during the night. She mentioned she had experienced some side effects which went away after a few days. She had herself tested last 06Jan2021 (also reported as 07Jan2021, pending for clarification) for Covid-19 antibodies which turned out positive and PCR which turned out negative. The outcome of the event "Covid antibodies which turned out positive" was unknown, while outcome of other events was recovered in Jan2021.

Other Meds:

Current Illness:

ID: 1037756
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Before his 2nd dose, he was diagnosed with COVID and was given bamlanivimab; Before his 2nd dose, he was diagnosed with COVID and was given bamlanivimab; This is a spontaneous report from a contactable consumer. A male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on an unspecified date for COVID-19 immunisation. Medical history and concomitant medication were not reported. Patient received 1st dose of vaccine. Before his 2nd dose, he was diagnosed with COVID and was given bamlanivimab. It was planned to wait 90 days before giving him any additional vaccine. Reporter also asked should patient receive one more dose or restart the series. The outcome of events was unknown. Information about Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 1037757
Sex: F
Age:
State:

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: diarrhea; headache; This is a spontaneous report from a Non-contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced diarrhea and headache both on 28Jan2021. The outcome was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1037758
Sex: M
Age:
State: SC

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Pain in arm; This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received the first dose of bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration, on 26Jan2021 08:00 AM at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history was none. The patient had no known allergies to medications, food, or other products. The patient had no concomitant medications. On 26Jan2021 02:00 PM, the patient experienced pain in arm. No treatment was received for the event. Outcome of the event was recovering. Since the vaccination, the patient has not been tested for COVID-19. The reporter assessed the event as non-serious. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037759
Sex: M
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Pain on injection site; This is a spontaneous report from a contactable consumer (patient). A 47-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. Medical history type 1 diabetes. The patient's concomitant medications were not reported. The patient experienced pain on injection site 18 hours following first dose of BNT162b2 COVID-19 vaccine. The outcome was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1037760
Sex: F
Age:
State: RI

Vax Date: 01/28/2021
Onset Date: 01/29/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Sore arm at the injection site; slight headache; This is a spontaneous report from a contactable consumer (Pfizer colleague) reported for herself. A 33-year-old female patient (not pregnant at the time of vaccination) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration at left arm on 28Jan2021 09:30 at SINGLE DOSE for covid-19 immunization. Medical history was none. There were no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient had no other medications received within 2 weeks of vaccination. The patient experienced sore arm at the injection site, and a slight headache both on 29Jan2021. The patient did not receive treatment for the adverse event. Since the vaccination, the patient had not been tested for COVID-19. The outcome was recovering. The seriousness from reporter was non-serious.

Other Meds:

Current Illness:

ID: 1037761
Sex: F
Age:
State: CT

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Experienced loss of appetite; mild nausea; headache; very mild body aches; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection; lot number: EL3247; expiry date: unknown) via an unspecified route of administration in the left arm, on 28Jan2021 at 09:15, at a single dose, for COVID 19 immunization. The patient had no relevant medical history and had no known allergies. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (BLISOVI 24 FE). It was unknown if the patient is pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the workplace clinic. On 28Jan2021, at 18:00, the patient experienced loss of appetite/mild nausea, headache, and very mild body aches. The events were considered non-serious. The patient did not receive treatment for the events. Outcome of the events was recovering/resolving. The patient has not been tested for COVID-19 since vaccination.

Other Meds: BLISOVI 24 FE

Current Illness:

ID: 1037762
Sex: F
Age:
State: CT

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: fatigue; chills; mild persistent headache (checked but, no fever); severe arm soreness at injection site/could not lift arm; severe arm soreness at injection site/could not lift arm; This is a spontaneous report from a contactable healthcare professional (patient). A 42-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration at right arm on 08Jan2021 at a single dose for COVID-19 immunization. The patient medical history was not reported. The patient was not pregnant at the time of vaccination. The patient had no allergies to medications, food, or other products. Concomitant medications included ethinylestradiol, levonorgestrel (ALESSE) for birth control, ascorbic acid, biotin, boron citrate, calcium pantothenate, calcium phosphate, choline bitartrate, chromium picolinate, colecalciferol, cyanocobalamin, dl-alpha tocopheryl acetate, folic acid, inositol nicotinate, potassium iodide, pyridoxine hydrochloride, retinol palmitate (VITAFUSION WOMEN'S) and cetirizine. The patient previously received BNT162B2 (COVID Pfizer) first dose in Dec2020 for COVID-19 immunization. On 09Jan2021, the patient experienced fatigue, chills, mild persistent headache (checked but, no fever), severe arm soreness at injection site and could not lift arm. Symptoms began about 12 hours after vaccination. The patient did not receive treatment for the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered in Jan2021. Information on the lot/batch number has been requested.

Other Meds: ALESSE; VITAFUSION WOMEN'S; CETIRIZINE

Current Illness:

ID: 1037763
Sex: F
Age:
State: NJ

Vax Date: 01/28/2021
Onset Date: 01/29/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Swelling of neck,shoulder, and arm; Swelling of neck,shoulder, and arm; Swelling of neck,shoulder, and arm; Temperature of 101; Body aches; Spasms in both legs; This is a spontaneous report from a contactable nurse (patient). A non-pregnant adult female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN5519), intramuscular in right arm, on 28Jan2021 at 15:30 (03:30 PM), at a single dose, for COVID-19 immunization. The patient's medical history included allergies to shellfish and dyes or derivative. The patient's concomitant medication included losartan. The patient previously took the first dose of BNT162B2 (Lot Number: EL3246) on 07Jan2021 at 04:00 PM for COVID-19 immunization (intramuscular in right arm). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in a workplace clinic facility. On 29Jan2021 at 01:00 AM, the patient experienced swelling of neck, shoulder, and arm; temperature of 101; body aches; and spasms in both legs. The events were considered non-serious. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the events.

Other Meds: LOSARTAN

Current Illness:

ID: 1037764
Sex: F
Age:
State: SC

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: her adverse event as having absolutely no saliva at all about 2-3 minutes later after getting the COVID-19 vaccine; did not have a good night's sleep; anxious; This is a spontaneous report from a contactable consumer reporting for herself. A 79-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number unknown reported as "EL9281 or EL9261" as the reporter cannot tell, pending clarification, expiry date: 31May2021), via an unspecified route of administration on 28Jan2021 12:00 at SINGLE DOSE (first dose) for covid-19 immunisation. Medical history included COPD from an unspecified date (not taking any medication for COPD) and she was 5'5 and has gotten a little bit tinier on an unspecified date. The patient's concomitant medications were not reported. On 28Jan2021, the patient stated everything was perfect and she was made to sit there for 15 minutes. The patient reported her adverse event as having absolutely no saliva at all about 2-3 minutes later after getting the COVID-19 vaccine. Her mouth stopped producing the saliva almost immediately and it was total. She stated she never had anything like that before. She stated it did not make her feel ill. She was still breathing alright, so she did not tell anybody. She did not have a good night's sleep and anxious about whether she won't be able to breathe with this experience. At 07:00 the next day, everything went back to normal and it was very noticeable for her. She was concerned about taking the second shot in 3 weeks considering her experience with the first shot. The patient stated afterwards that the information provided to her helped her to be relived and be confident about taking the second shot. Outcome of the event was recovered on 29Jan2021 07:00. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037765
Sex: F
Age:
State:

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Wrist bone is swollen on the right arm where she received vaccine; This is a spontaneous report from a non-contactable consumer (patient). A 67-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration in the right arm on 29Jan2021 16:00 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has been tested for COVID-19. On 29Jan2021 19:00, the patient experienced that wrist bone was swollen on the right arm where she received vaccine. The patient underwent lab tests and procedures which included SARS-COV-2 test: negative on 14Dec2020. No therapeutic measure was taken as a result of the events. Clinical outcome of the event was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1037766
Sex: F
Age:
State: CA

Vax Date: 01/01/2021
Onset Date: 01/13/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Wheezing; Dry cough at rest or while talking; This is a spontaneous report from a contactable healthcare professional (patient). A non-pregnant 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), intramuscular in left arm, in Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medications included Cichorium intybus extract/ Embelia ribes powder/ Glycyrrhiza glabra extract/ Operculina turpethum extract/ Senna occidentalis extract/ Solanum nigrum extract/ Terminalia chebula extract/ Zingiber officinale powder (HERBOLAX), levothyroxine sodium (SYNTHROID), sertraline hydrochloride (ZOLOFT), and ezetimibe (ZETIA). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The most recent COVID-19 vaccine was administered in a public health clinic. On 13Jan2021 at 07:00 PM (19:00), the patient experienced wheezing within 2 to 3 days and dry cough at rest or while talking. The events were considered non-serious. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the events. Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.

Other Meds: HERBOLAX [CICHORIUM INTYBUS EXTRACT;EMBELIA RIBES POWDER;GLYCYRRHIZA GLABRA EXTRACT;OPERCULINA TURPE; SYNTHROID; ZOLOFT; ZETIA

Current Illness:

ID: 1037767
Sex: F
Age:
State: TX

Vax Date: 01/18/2021
Onset Date: 01/19/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: chills; temp got to 103.5 (fever); swollen, sore glands to the left side of my jaw, underneath and in front of my ear; swollen, sore glands to the left side of my jaw, underneath and in front of my ear/gland pain; nasal drainage to my left sinus/nostril; inside of her left cheek felt like there were lesions breaking out but there were none; her cheek and teeth were sore, as if she had a sinus infection; her cheek and teeth were sore, as if she had a sinus infection; sinus drainage became blood tinged. It is pale pink in in color, not constant/bloody drainage; This is a spontaneous report from a contactable nurse (patient). A 52-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249, expiry date not reported), via an unspecified route of administration in the left arm on 18Jan2021 at single dose for COVID-19 immunization. Medical history included hypertension from an unspecified date and appendectomy in 1991. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medication included hydrochlorothiazide, lisinopril (LISINOPRIL AND HYDROCHLOROTHIAZIDE). The patient previously took atropine sulfate (SULFAS ATROPINE, reported as Sulfa), quinolones and doxycycline and experienced drug hypersensitivity. The patient previously received first dose of bnt162b2 (lot number: EL0142, expiry date not reported) in the left arm on 30Dec2020 at 5:30PM at single dose for COVID-19 immunisation. On 19Jan2021 02:00, she started with chills and by 24 hours, her temp got to 103.5 (fever). The patient took Tylenol. The temp stayed in the 100-101 range for the next 24 hours. Then, she started to have swollen, sore glands to the left side of her jaw, underneath and in front of her ear. The inside of her left cheek felt like there were lesions breaking out but there were none. She then had copious amounts of thin nasal drainage to her left sinus/nostril. Over the next few days, the gland pain subsided but she still had drainage and her cheek and teeth were sore, as if she had a sinus infection. She would occasionally take Tylenol and on occasion, took cold and flu medicine. Then, her sinus drainage became blood tinged. It was pale pink in in color, not constant, but when the drainage started, it was sudden and just drained with no warning. She smelled old blood. She turned in bed and the drainage occurred suddenly and she can taste old blood. Almost two weeks later, and she still had bloody drainage. Clinical outcome of the events was not recovered.

Other Meds: LISINOPRIL AND HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1037768
Sex: F
Age:
State: IL

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: tingling and numbness in hands and feet; tingling and numbness in hands and feet; weakness; fatigue; muscle and joint pain; muscle and joint pain; chills; fever of 100.4 F; headache; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 28-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262 and expiry date unknown), via an unspecified route of administration on 26Jan2021 18:00 at a single dose on the left arm for COVID-19 immunization. Medical history included asthma, fibromyalgia, ADHD, GERD, IBS, and allergies to pollen and yellow onions. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), diltiazem, and topiramate. Patient is not pregnant at the time of vaccination. The patient received the first dose of bnt162b2 on 05Jan2021 15:00 (lot number: EL1284) on the left arm. The patient was not diagnosed with COVID-19 prior to vaccination. Patient was tested for COVID-19 post-vaccination: Tempus iC SARS-CoV-2 RT-PCR on 28Jan2021 with result negative. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Jan2021 14:00, within 24 hours after administration of second dose, patient began experiencing tingling and numbness in hands and feet, weakness, fatigue, muscle and joint pain, chills, fever of 100.4 F, headache, and nausea, in that order developing over the next 48 hours. Patient has not recovered from the events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse events includes Tylenol. Events reported as non-serious.

Other Meds: WELLBUTRIN; DILTIAZEM; TOPIRAMATE

Current Illness:

ID: 1037769
Sex: F
Age:
State: MD

Vax Date: 01/25/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: suffered ocular migraine; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration at the left arm on 25Jan2021 09:30 at single dose for COVID-19 immunization. Medical history was none. Concomitant medication was not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a public health clinic/veterans administration facility. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient suffered ocular migraine on 26Jan2021 22:00. No treatment was received for the adverse event. Clinical outcome of the event was recovered on an unspecified date. No follow up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1037770
Sex: U
Age:
State:

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Mild sore arm; muscle ache into shoulder blade and neck for 36 hours; muscle ache into shoulder blade and neck for 36 hours; muscle ache into shoulder blade and neck for 36 hours; mild fatigue for 72 hours at minimum; low grade headache for 48 hours; This is a spontaneous report from a non-contactable consumer (patient). A 33-year-old patient of an unspecified gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: E132495121, expiry date not reported), via an unspecified route of administration on 27Jan2021 14:00 at single dose for COVID-19 immunization. Medical history included food allergy (garlic, oatmeal, turkey, chickpeas/garbanzo beans). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included vitamin d nos (VITAMIN D). On 27Jan2021 17:00, the patient experienced mild sore arm and muscle ache into shoulder blade and neck for 36 hours, mild fatigue for 72 hours at minimum, low grade headache for 48 hours. The patient underwent lab tests and procedures which included SARS-COV-2 test with pending result since 29Jan2021. No treatment was received for the adverse events. Clinical outcome of the events was recovering. No follow up attempts are possible. No further information is expected.

Other Meds: VITAMIN D

Current Illness:

ID: 1037771
Sex: F
Age:
State: TX

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Cold hands and feet; Chills; Back of the head aches; Stinging in injection arm; This is a spontaneous report from a contactable consumer. A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL 9265, expiry date: unknown), via an unspecified route of administration in the left arm, on 28Jan2021, at single dose, for covid-19 immunization, at an urgent care center. Medical history included known allergies to seafood. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. Concomitant medication included metformin, and hydrochlorothiazide, telmisartan. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2 vaccine. The patient experienced cold hands and feet, chills, back of the head aches and stinging in injection arm on 28Jan2021. No treatment was given for the events. The patient was recovering from the events. The events were assessed as non-serious.

Other Meds: METFORMIN; TELMISARTAN/HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1037772
Sex: F
Age:
State: AZ

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Extreme fatigue; Stuffy nose; Runny nose; Coughing; Sore throat at night; Slight headache; Temperature up only one degree; Chills; Unable to sleep; Body ache; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 71-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9263), via an unspecified route of administration in left arm, on 22Jan2021 at 12:30 PM, at a single dose, for COVID-19 immunization. The patient's medical history included slightly high blood pressure and depression. The patient was taking unspecified concomitant medications. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Jan2021 at 12:15 PM, the patient experienced extreme fatigue, stuffy nose followed by runny nose, coughing and sore throat at night, slight headache, temperature up only one degree but chills, and unable to sleep due to body ache. These events ended quite abruptly on 29Jan2021. The events were considered non-serious. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from the events on 29Jan2021.

Other Meds:

Current Illness:

ID: 1037773
Sex: M
Age:
State: IN

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Extreme fatigue; headache; diarrhea; stomach pain; joint pain; chills; upset stomach; This is a spontaneous report from a contactable consumer (patient). A 46-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown, expiry date not reported), via an unspecified route of administration in the left arm on 29Jan2021 18:15 at single dose for COVID-19 immunization. Medical history included COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications were not reported. The patient previously received first dose of bnt162b2 (lot number: unknown, expiry date not reported) in the left arm on 08Jan2021 07:15 PM at single dose for COVID-19 immunization. On 30Jan2021 13:00, the patient experienced extreme fatigue, headache, diarrhea, stomach pain, joint pain, chills, and upset stomach. No therapeutic measure was taken as result of the events. Clinical outcome of the events was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037774
Sex: F
Age:
State: MD

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: My ankles were bright red, extremely itchy, and swollen with a eczema like rash formed around them.; My ankles were bright red, extremely itchy, and swollen with a eczema like rash formed around them.; My ankles were bright red, extremely itchy, and swollen with a eczema like rash formed around them.; My ankles were bright red, extremely itchy, and swollen with a eczema like rash formed around them.; This is a spontaneous report from a contactable healthcare professional (patient). A 45-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot number: EL1283), at age 45 years, intramuscular on the right arm, on 29Jan2021 09:00 at single dose, for COVID-19 immunisation. Medical history included allergy to red wasp bee stings. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient's concomitant medications were not reported. On 30Jan2021 01:00, patient's ankles were bright red, extremely itchy, and swollen with a eczema like rash formed around them. Patient soaked her ankles and took some diphenhydramine (BENADRYL) and ibuprofen (MOTRIN). She also applied triamcinolone acetonide cream usp. and oatmeal (EUCERIN ECZEMA RELIEF BODY CREAM). She mentioned that it is not resolved by Tuesday, she will visit urgent care. Facility where the most recent COVID-19 vaccine was administered was at a hospital. Since the vaccination, the patient has not been tested for COVID-19. The adverse event resulted in emergency room/department or urgent care. The outcome of the events was not recovered. Case was reported as non-serious.

Other Meds:

Current Illness:

ID: 1037775
Sex: F
Age:
State: AR

Vax Date: 01/23/2021
Onset Date: 01/24/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Abdominal pain; severe nausea; headache; numbness in hand; itching on body on the side on injection; itching on body on the side on injection; dizziness; insomnia; night sweats; low grade fever; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient started to received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: unknown, unable to locate or read details), via an unspecified route of administration on 23Jan2021 16:15 (04:15 PM) at single dose on right arm for COVID-19 immunization. Patient was not pregnant at the time of report. The patient medical history was not reported. Patient was not diagnosed with COVID-19 prior vaccination. Concomitant medications included fluticasone, salmeterol, montelukast and paracetamol (TYLENOL). Patient did not receive any other vaccines within 4 weeks prior to COVID vaccine. The most recent COVID-19 vaccine was administered in School or Student Health Clinic The patient experienced abdominal pain, severe nausea, headache, numbness in hand, itching on body on the side on injection, dizziness, insomnia, night sweats, low grade fever, all on 24Jan2021 02:00. No treatment was received for the events. The events were assessed as non-serious. Outcome of the events was recovering. Patient has not been tested with COVID-19 since the vaccination. Information on the lot/batch number has been requested.

Other Meds: FLUTICASONE; SALMETEROL; MONTELUKAST; TYLENOL

Current Illness:

ID: 1037776
Sex: F
Age:
State: NC

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Joint pain; had liquid diarrhea; Stomach not crampy but urgency when it happens; Medical history include coeliac disease; This is a spontaneous report from a contactable consumer (patient). A 68-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL9262; expiration date: unknown), via an unspecified route of administration right arm on 23Jan2021 11:00 at a single dose for covid-19 immunization. Medical history included essential tremor, coeliac disease, high blood pressure, and allergies to wheat and dairy. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included enalapril (ENALAPRIL), venlafaxine hydrochloride (EFFEXOR), propranolol and hydrochlorothiazide (HCT). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported for about a week, she has had liquid diarrhea. The patient also has joint pain, stomach not crampy but urgency when it happens and no fever. The patient did not received treatment for the adverse events and the event was non-serious. The patient has not been tested for COVID-19 since the vaccination. The onset of the events was on 26Jan2021 and the outcome of the events was not recovered.

Other Meds: ENALAPRIL; EFFEXOR; PROPRANOLOL; HCT

Current Illness:

ID: 1037777
Sex: F
Age:
State: PA

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Fever over 100 degrees; swollen lymph nodes; unable to swallow; This is a spontaneous report received from a contactable other healthcare professional (who is also the patient). A 19-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248, expiry date unknown), via an unspecified route of administration in the left arm, on 30Jan2021 07:30, at single dose, for COVID-19 immunization, at the hospital. The patient medical history was not reported. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. Concomitant medication included an unspecified birth control medication. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2 vaccine. The patient experienced "fever over 100 degrees and swollen lymph nodes causing me to be unable to swallow" on 30Jan2021 at 22:00. No treatment was received for the events. The outcome of the events was not resolved. The reporter assessed the events as non-serious.

Other Meds:

Current Illness:

ID: 1037778
Sex: F
Age:
State: TX

Vax Date: 01/25/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Bruise on left arm; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration on 25Jan2021 08:15 PM at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at School or Student Health Clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history was none. The patient has no known allergies to medications, food, or other products. Concomitant medications included iron, birth control, prenatal vitamins. On 26Jan2021, the patient experienced bruise on left arm. No treatment was received for the events. Outcome of the event was not recovered. The reporter assessed the events as non-serious. Since the vaccination, the patient not been tested for COVID-19. Information on the lot/batch number has been requested.

Other Meds: IRON

Current Illness:

ID: 1037779
Sex: F
Age:
State: NY

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Dry cough; Fatigued; Bitemporal headache 4/10 with 10 being the worst; Fever started within 6 hours after the vaccine/The next day temp increased to 100.3; This is a spontaneous report from a contactable physician. A 58-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on her left arm, via an unspecified route of administration on 29Jan2021 09:45 at a single dose for covid-19 immunization. Medical history included Rheumatoid Arthritis, Menieres disease and history of 6 pneumonia episodes 4 during childhood 2 as an adult. The patient previously took bactrim, augmentin and malarone; all of which the patient had allergies to. It was reported that Fever started within 6 hours after the vaccine. Initially 99.8 in the evening of the day I was vaccinated. Also, dry cough which lasted about 5 hours and was gone after that. The next day temp increased to 100.3. This lasted until 24 hours after vaccination when it abruptly ended. However, patient continued to be very fatigued. Also, several hours after vaccination, bitemporal headache 4/10 with 10 being the worst which ended approximately 24 hrs after vaccination; all on 29Jan2021 at 3:00PM. The patient receive acetaminophen for the events. The outcome of the event dry cough recovered in 29Jan2021, headache recovered on 30Jan2021, not recovered for event fatigue, while recovering for fever. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037780
Sex: M
Age:
State: MO

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: skin irritation and discoloring; skin irritation and discoloring; severe hives; This is a spontaneous report from a contactable consumer (patient). An 86-year-old male patient receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration (right arm) on Jan2021 at single dose for Covid-19 immunization. The patient's medical history included Heart (heart disorder), diabetes, and allergy: life long allergies. The patient concomitant medication includes unspecified medication. The patient previously took Zocor, Cardura, Accupril, Niacin, Clonidine HCl; all tabs and experienced allergies. In Jan2021, the patient experienced skin irritation and discoloring starting the day of vaccine and increasing into severe hives the following days. Currently on day 6 with no relief. The patient did not received treatment for the events. The outcome of the events was not recovered. The reporter assesses the events as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Information on the Lot/Batch number has been requested

Other Meds:

Current Illness:

ID: 1037781
Sex: F
Age:
State: MN

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: My lymph node in my neck swelled to the point it stuck out like a robin egg; sores in mouth (roof, gums, and inside lips); sores in nostril; sores on nose and lips; sores on nose and lips; Face swelled significantly on my left side; pink eye; severe headache; sinus pain; jaw main and numbness in my molars; severe shooting nerve pain in my front teeth; This is a spontaneous report from a contactable consumer (patient). A 47-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL9262; expiration date: unknown), via an unspecified route of administration right arm on 23Jan2021 18:45 at a single dose for covid-19 immunization. Medical history included breast cancer survivor as of 11Sep2019. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included venlafaxine hydrochloride (EFFEXOR), clonazepam, anastrozole (ARIMIDEX), vitamin D3, calcium, vitamins NOS (MULTIVITAMIN), "It Works" and "Fat Fighter". The patient previously took fentanyl but had allergies. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that her lymph node in her neck swelled to the point it stuck out like a robin egg. It was mentioned that it was more swelled there as well and super sensitive to touch. These reactions occurred only on left side of her face, sores in mouth (roof, gums, and inside lips) and sores in nostril. She had sores on nose and lips. The patient mentioned that her face swelled significantly on her left side. She had pink eye, severe headache, sinus pain, jaw main and numbness in her molars, severe shooting nerve pain in her front teeth. The events were considered as non-serious and adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient has not been tested for COVID-19 since vaccination. The events required treatment for the adverse events that included Keflex, Bactroban, prednisone, Valtrex, and lidocaine viscous-aluminum &magnesium hydrAM. The outcome of the events was recovering.

Other Meds: EFFEXOR; CLONAZEPAM; ARIMIDEX; VITAMIN D3; CALCIUM; MULTIVITAMINS [VITAMINS NOS]

Current Illness:

ID: 1037782
Sex: F
Age:
State: GA

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Rash; blurred vision; loss of balance; headache; nausea; This is a spontaneous report from a contactable other health care professional (patient). A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3302 and expiration date not provided), via an unspecified route of administration (left arm) first dose on 27Jan2021 08:30 at single dose for Covid-19 immunization. The patient was not pregnant at time of vaccination. The Patient's medical history included Hbp (Blood pressure high). The Patient's concomitant medication included lisinopril, famotidine, and ferrous sulfate. The patient previously took Procardia and Amoxicillin; both experienced allergies. On 28Jan2021, the patient experienced rash, blurred vision, loss of balance, headache, and nausea. The patient did not received treatment for the events. The outcome of the events was recovering. The reporter assesses the events as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered in the Hospital. The patient did not tested for covid since vaccination.

Other Meds: LISINOPRIL; FAMOTIDINE; FERROUS SULFATE

Current Illness:

ID: 1037783
Sex: F
Age:
State: OK

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Injection site was moderately sore; I felt extremely tired and fatigued; chilled to the bone alternating with hot spells; This is a spontaneous report from a contactable consumer. A 53-year-old female consumer reported that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL8982), into the left arm on 29Jan2021 at 10:30 at single dose for COVID-19 immunization. Age at vaccination 53 Years. The patient had received first dose of BNT162B2 on 09Jan2021. The patient had no allergies to medications, food, or other products. Medical history was none. Concomitant drugs included Prozac daily and Lyrica one daily. The patient reported that the injection site was moderately sore. The main side effect started 24 hours post shot. She felt extremely tired and fatigued as well as chilled to the bone alternating with hot spells. No body aches. No other effects. No treatment was received. Resolved in 24 hours.

Other Meds: PROZAC; LYRICA

Current Illness:

ID: 1037784
Sex: F
Age:
State: KS

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Moderate to severe muscle aches; joint pain; fatigue; This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number: EK9231, expiry date: not reported), via an unspecified route of administration on 07Jan2021 05:30 PM at a single dose on the right arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history included arthritis, hypersomnia, depression, anxiety, IBS (irritable bowel syndrome) and allergy to sulfa. Concomitant medications included desvenlafaxine succinate (PRISTIQ), modafinil (MODAFINIL), fluticasone propionate (FLONASE), ibuprofen (IBUPROFEN). The patient previously received the first dose of bnt162b2 (BNT162B2, lot number: EK5730) on 16Dec2020 05:30 PM at a single dose on the right arm for COVID-19 immunization (age at vaccination: 37-year-old). On 08Jan2021 07:00 AM, the patient experienced moderate to severe muscle aches, joint pain, and fatigue. No treatment was received for the events. Outcome of the events was recovered/resolved with sequel. The reporter assessed the events as non-serious. Since the vaccination, the patient not been tested for COVID-19.

Other Meds: PRISTIQ; MODAFINIL; FLONASE [FLUTICASONE PROPIONATE]; IBUPROFEN

Current Illness:

ID: 1037785
Sex: F
Age:
State: KY

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: lymph node soreness size of small orange/enlarged lymph node; Fever of 103.4/Day 3 still temp of 100; lymph node soreness size of small orange; This is a spontaneous report from a contactable nurse. A 55-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0140) on her left arm, via an unspecified route of administration on 29Jan2021 09:30 at a single dose for covid-19 immunization. Medical history included asthma. Patient previously took codeine and experienced allergies. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Jan2021 (first dose). The patient experienced Fever of 103.4 lymph node soreness size of small orange on 30Jan2021 at 01:00AM. Day 3 still temp of 100 and enlarged lymph node. The patient also had a covid test on 24Jan2021 which tested negative.

Other Meds:

Current Illness:

ID: 1037786
Sex: F
Age:
State: FL

Vax Date: 01/22/2021
Onset Date: 01/29/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Hives on breasts, under breasts, chest, lower stomach, on back, under both arms; Hives/ a small one on injection site; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL9262) on her left arm, via an unspecified route of administration on 22Jan2021 14:30 at a single dose for covid-19 immunization. Medical history included arthritis, penicillin allergy, sulphas allergy and Celpholasporins allergy. Concomitant medication included atorvastatin calcium (LIPITOR). The patient previously took sporanox and nitrofurantoin and experienced allergies. It was reported that the patient experienced Hives on breasts, under breasts, chest, lower stomach, on back, under both arms, and a small one on injection site on 29Jan2021 at 10:00PM. The patient received Prednisone twice a day for 5 days as treatment for the events on the emergency room (visit). The outcome of the events was recovering.

Other Meds: LIPITOR [ATORVASTATIN CALCIUM]

Current Illness:

ID: 1037787
Sex: M
Age:
State: AZ

Vax Date: 01/18/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: excruciating pain on the left side my face; rash and swelling on the left side of my face; rash and swelling on the left side of my face; swelling of tongue; tingling in the face and tongue; tingling in the face and tongue; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received the first dose of bnt162b2 (BNT162B2, lot number: el3247, expiry date: not reported), via an unspecified route of administration on 18Jan2021 03:45 PM at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history was none. The patient had no known allergies to medications, food, or other products. The patient had no concomitant medications. On 26Jan2021 06:00 AM, the patient experienced "excruciating pain on the left side my face and then noticed a rash and swelling on the left side of my face and swelling of tongue. Also tingling in the face and tongue." Therapeutic measures received as a result of adverse events included prescribed medication. Adverse events resulted into doctor or other healthcare professional office/clinic visit, emergency room/ department or urgent care. Outcome of the events was not recovered. The reporter assessed the events as non-serious. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 26 October 2021 2:21am